PAR-101

Known as: PAR 101, PAR101 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2014
01220082014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
BACKGROUND Due to the limitations of existing treatment options for Clostridium difficile infection (CDI), new therapies are… (More)
  • figure 1
  • table 2
Is this relevant?
Review
2014
Review
2014
OBJECTIVE To review the chemistry, pharmacology, microbiology, pharmacodynamics, pharmacokinetics, clinical efficacy… (More)
Is this relevant?
Review
2012
Review
2012
The two drugs currently recommended for the treatment of Clostridium difficile infection (CDI), namely vancomycin and… (More)
  • figure 1
  • table 1
Is this relevant?
Review
2012
Review
2012
OBJECTIVE To evaluate the pharmacology, microbiology, safety, and efficacy of fidaxomicin for treatment of Clostridium difficile… (More)
Is this relevant?
2010
2010
The effects of the inoculum, pH, cation concentrations, and different lots of commercial media on the in vitro susceptibility of… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
Review
2008
Review
2008
BACKGROUND Clostridium difficile-associated diarrhoea has become a major problem over the last years. Increasing incidence and… (More)
Is this relevant?